BIOMAT Database Logo BIOMAT Database Logo

Effect of template secondary structure on the inhibition of HIV-1 reverse transcriptase by a pyridinone non-nucleoside inhibitor. 1994

D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
Department of Biological Chemistry, Merck Research Laboratories, Merck & Co., West Point, PA 19486.

The importance of RNA secondary structure on HIV-1 reverse transcriptase catalyzed polymerization and on the potency of the pyridin-2-one inhibitor 3-(4,7-dichlorobenzoxazol-2-ylmethylamino)-5-ethyl-6-meth ylpyridin-2(1H)-one, L-697,661, were investigated by employing heteromeric primer-template systems. Our data revealed that a stem-loop hairpin secondary structure in the RNA template could lead to strong hindrance of reverse transcription in the reaction catalyzed by HIV-1 reverse transcriptase resulting in the build up of intermediate-length (pause) polymerization products. The presence of L-697,661 greatly enhanced the accumulation of the pause products suggesting that the rate of enzyme translocation from the pause product might be more potently inhibited than polymerization up to the pause site. Model experiments using a synthetic RNA template containing a stem-loop hairpin revealed that the inhibitory potency of L-697, 661 increased 2-fold upon polymerization to within four bases of the secondary structure. Inhibitor potency was enhanced over 6-fold when primer-extension proceeded through the duplex region of the stem-loop.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D011728 Pyridones Pyridine derivatives with one or more keto groups on the ring. Pyridinones
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D005914 Globins A superfamily of proteins containing the globin fold which is composed of 6-8 alpha helices arranged in a characterstic HEME enclosing structure. Globin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001583 Benzoxazoles Benzoxazole

Related Publications

D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
QSAR study on pyridinone derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitor: a mixed approach.
May 2007, Medicinal chemistry (Shariqah (United Arab Emirates)),
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
ANN QSAR workflow for predicting the inhibition of HIV-1 reverse transcriptase by pyridinone non-nucleoside derivatives.
July 2017, Future medicinal chemistry,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase.
December 2004, Bioorganic & medicinal chemistry,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
A novel, non-nucleoside inhibitor of HIV-1 reverse transcriptase.
January 1992, Advances in experimental medicine and biology,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
[RILPIVIRINE -- a novel HIV-1 non-nucleoside reverse transcriptase inhibitor].
March 2013, Klinicka mikrobiologie a infekcni lekarstvi,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
The effect of template RNA structure on elongation by HIV-1 reverse transcriptase.
March 1999, Biochimica et biophysica acta,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
Delavirdine mesylate, a potent non-nucleoside HIV-1 reverse transcriptase inhibitor.
January 1996, Advances in experimental medicine and biology,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
Mechanism of inhibition of HIV-1 reverse transcriptase by non-nucleoside inhibitors.
April 1995, Nature structural biology,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
Interaction kinetic characterization of HIV-1 reverse transcriptase non-nucleoside inhibitor resistance.
April 2006, Journal of medicinal chemistry,
D B Olsen, and S S Carroll, and J C Culberson, and J A Shafer, and L C Kuo
Identification of a dibenzocyclooctadiene lignan as a HIV-1 non-nucleoside reverse transcriptase inhibitor.
February 2015, Antiviral chemistry & chemotherapy,
Copied contents to your clipboard!